Å»¸ð ¼¼¹Ì³ª
1.ÀϽÃ: 2015³â 2¿ù 8ÀÏ(ÀÏ¿äÀÏ) ¿ÀÈÄ 1:00-¿ÀÈÄ 5:00 2. Àå¼Ò: ºÎ»ê ½Ã¹Îȸ°ü ¼Ò¿¬È¸½Ç( *¼Ò±ØÀåÀ» ÁÂÃøÀ¸·Î µ¹¾Æ¼ µ¿Ãµ¹æÇâ 3Ãþ) 3. ¿À½Ã´Â ¹æ¹ý: a: ºÎ»ê ÁöÇÏö 2È£¼± ¹®Çö¿ª 1¹ø Ãⱸ b: ºÎ»ê¿ª¿¡¼ Åý÷Π±âº»¿ä±Ý ¾à°£ »óȸ 4. Á¢¼ö¹æ¹ý: a ÇÚµåÆù 010-5528-4014¿¡ ¹®ÀÚ·Î ÀÔ·ÂÇØÁÖ¼¼¿ä(À̸§, ÀüȹøÈ£,º´¿øÀ̸§ *º¯µ¿ »óȲÀÌ ÀÖÀ» ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù) b. À̸ÞÀÏ aquajis@hanmail.net c À̸§, ÀüȹøÈ£(ÇîµåÆù Æ÷ÇÔ), ÀÇ»ç¸éÇã¹øÈ£ º´¿øÀ̸§À» ²À ³Ö¾îÁÖ¼¼¿ä 5. Âü°¡ºñ¿ë: 14¸¸¿ø(*ÇöÀå µî·Ï 16¸¸¿ø) ÇϳªÀºÇà: 320 810001 18908 Á¤Àμ÷ 6. ¿¬¶ô: 010-2510-4014(Á¤Àμ÷)
**¼¼¹Ì³ª ³»¿ë 1. ³²¼ºÇü Å»¸ð(´ë¸Ó¸®)ÀÇ Á¾ÇÕÀûÀÎ Ä¡·á( À¯ÀüÀû, È£¸£¸ó, ¿µ¾ç, ¼øȯ, ½ºÆ®·¹½º, Å»µ¶¼ÒÈ, ¸Ó¸®¿Í ¸ñÀÇ ±ÙÀ°, ¸ð¹ß Áٱ⼼Æ÷Àû, ´ëüÀÇÇÐÀû °üÁ¡) 2.»çÃá±â û¼Ò³âÀÇ ³²¼ºÇü Å»¸ðÀÇ Ä¡·á 3, ¿©¼ºÀÇ ³²¼ºÇü Å»¸ð(¿©ÀÚ ´ë¸Ó¸®)ÀÌ ³²ÀÚÀÇ ³²¼ºÇü Å»¸ðº¸´Ù Ä¡·áÀÇ ¾î·Á¿îÁ¡°ú Ä¡·áÀÇ Â÷ÀÌÁ¡. 4. ¿©¼ºÀÇ ³²¼ºÇü Å»¸ð(¿©ÀÚ ´ë¸Ó¸®)¿¡¼ ¸¸¼º½ºÆ®·¹½º, ºÎ½ÅÇÇ·Î(ºÎ½Å°í°¥)°úÀÇ »óÈ£°ü°è 5. Æó°æ±â ¿©¼º¿¡¼ÀÇ ³²¼ºÇü Å»¸ð(¿©ÀÚ ´ë¸Ó¸®)ÀÇ Ä¡·á 6. ¿øÇüÅ»¸ðÀÇ Á¾ÇÕÀûÀÎ Ä¡·á 7. ¸ð¹ß Áٱ⠼¼Æ÷ *** Å»¸ð¿¡ ´ëÇÑ Àü¹® ¼¼¹Ì³ª°¡ °ÅÀÇ ¾ø´Â Áö±Ý, 5³â ¸¸¿¡ ¸ðó·³ ¿¸®°Ô µÇ´Â Å»¸ð ¼¼¹Ì³ª, ÃÖ±ÙÀÇ Å»¸ð Ä¡·á ¹æ¹ý°ú ¸¹Àº Å»¸ð ³í¹®¹ßÇ¥¿Í Å»¸ð Ã¥ ÀúÀÚÀÇ Á÷Á¢ °ÀÇ¿¡ ¸¹Àº µµ¿òÀÌ µÇ±â¸¦ ¹Ù¶ø´Ï´Ù ¾È³çÇϽʴϱî? ¾î·Á¿î ÀÇ·áȯ°æ¿¡¼ °í»ýÀÌ ³Ê¹« ¸¹À» ¼±ÈÄ¹è ¼±»ý´Ô²² »õÇØ º¹ ¸¹ÀÌ ¹ÞÀ¸½Ã°í °Ç°ÀÌ ÇÔ²² Çϱ⸦ ±â¿øÇÕ´Ï´Ù ÇÐȸ°¡ »ý±äÁö ¾î¾ð 9³â. Å»¸ðÀα¸´Â ±ÞÁõÇÏ°í Àα¸ÀÇ 25%Á¤µµ(1õ¸¸ ÀÌ»ó)¿¡ À̸£°í ÀÖ½À´Ï´Ù. ¼±»ý´ÔµéÀÌ Å»¸ð¿¡ ¼ÕÀ» ³õ°í ÀÖ´Â »çÀÌ Çѹ濡¼ ħ½ÄÇÏ°í ÀÖ´Â ¾ÈŸ±î¿î Çö½ÇÀÌ ¹ú¾îÁö°í ÀÖ½À´Ï´Ù. »ç½Ç Å»¸ð´Â Á¾ÇÕÀûÀÎ ÀÇÇÐÀÇ Ç¥»óÀÔ´Ï´Ù. ¿ì¸®¸ö¿¡¼ ÇÑ´Þ¿¡ 1cm¾¿ ÀÚ¶ó´Â Áï ´ë»ç°¡ À̸¸Å È°¹ßÇÑ °÷Àº °ñ¼ö¿Í ¸ð¹ß»ÓÀÔ´Ï´Ù, ±×¸¸Å ¿ì¸®¸öÀÇ ¾î¶² ÀåÇØ¿¡µµ ¿¹¹ÎÇÏ´Ù´Â Áõ°ÅÀÔ´Ï´Ù. ´ÜÁö ÅëÁõÀÌ ¾ø¾î ³Ñ¾î°¥ »ÓÀÌ°í ¸öÀÇ Áúº´ÀÌ ÀÖÀ» ½Ã ¸ð¹ßÀÇ Áõ»óÀÌ Ã¹¹ø°·Î ³ªÅ¸³ªÁö¸¸ ¹Ì¿ëÀûÀÎ ¸éÀ¸·Î Á¢±ÙÇؼ °£°úµÇ´Â °ÍÀÔ´Ï´Ù. ÀÌ·± Á¾ÇÕÀûÀÎ °ÍÀ» ¼±»ý´ÔµéÀÌ ÇÏÁö ¾ÊÀ¸¸é ¾î´À ´©±¸µµ ÇÒ ¼ö ¾ø°í ´ÜÁö ÆĶó¸ÞµðÄ®ÀÌ µæ¼¼ÇÒ »Ó ÀÔ´Ï´Ù. °íÇ÷¾Ð, ´ç´¢¸¦ ÇÕÄ£ Àα¸º¸´Ù ¸¹Àº Å»¸ðȯÀÚ¸¦ Å»¸ð´Â Ä¡·á°¡ ¾î·Æ´Ù´Â ÀνľƷ¡ ±×³É ¼ö¼ú(¸ð¹ß À̽Ä)¿¡¸¸ ÃÐÁ¡À» ¸ÂÃß´Â °ÍÀº ¿ì¸®ÀÇ ¿µ¿ªÀ» ÀÚ²Ù Á¼Çô³ª°¡´Â ÇൿÀÔ´Ï´Ù. Å»¸ð´Â µÎÇÇÀÇ ÁúȯÀÌ ¾Æ´Õ´Ï´Ù. ¸ðµç ÀÇÇÐÀû(³»°úÀû) Áö½ÄÀÌ Ãѵ¿¿øµÇ°í ¼±ÅõǾî Á®¾ß ÇÕ´Ï´Ù. Å»¸ð¸¦ ¿¬±¸ÇÏ´Ùº¸¸é ÀÇÇÐÀÇ ¿µ¿ªÀÌ ±²ÀåÈ÷ ³Ð¾îÁö°í Å»¸ð¸¦ Ä¡·áÇÒ ¶§ Æø³ÐÀº ÀÇÇÐÁö½ÄÀ» ¼ÒÀ¯ÇÒ ¶§ ȯÀÚ´Â ½Å·ÚÇÏ°í Ä¡·á¸¦ Àß ¼ö¿ëÇÏ°Ô µË´Ï´Ù. ´ëÇÑ ¹Î±¹¿¡ Å»¸ð¿¡ ´ëÇÑ Áö½Ä°ú Á¤º¸°¡ °ø±ÞµÇÁö ¾Ê°í ¿¬±¸°¡ ÀÌ·ç¿öÁö°í ÀÖÁö ¾Ê´Â »çÀÌ ¿ì¸®´Â Á¡Á¡ À§ÃàµÇ¾î °¡°í ÀÖ½À´Ï´Ù. º»Àεµ °ú°Å ¸¹Àº Å»¸ðÀÇÇÐ ¼Àû°ú Å»¸ð³í¹®À» ¹ßÇ¥ÇÏ¿´À¸³ª °°ÀÌ ¿¬±¸ÇÏ´Â µ¿·áÀǻ簡 º°·Î ¾ø¾î °ü½ÉÀ» Á¶±Ý ³õ°í ÀÖ´Â »çÀÌ ÇѹæÀÌ µæ¼¼¸¦ ÇÏ°í ÀÖ´Â ¸ð¾çÀ» º¼ ¼ö ¾ø¾î ÀÌÁ¦ ³ª¼°Ô µÇ¾ú½À´Ï´Ù. Å»¸ðÄ¡·áÀÇ ¼ÂÆÿ¡´Â º°·Î °æÁ¦ÀûÀÎ ºñ¿ëµµ ¾Èµé°í Å« ÀÇ·á±â±¸µµ ÇÊ¿ä¾ø½À´Ï´Ù,. ±â±¸´Â ¸ÞÁ¶°Ç Çϳª Á¤µµ¸¸ À־ ÇÒ ¼ö ÀÖ´Â Á¤µµ ÀÔ´Ï´Ù. ¸ÞÁ¶°Ç°ú ¸ÞÁ¶¾à¹°ÀÌ Áß¿äÇÏ°í Ä¡·áÇÏ´Â °ÍÀÌ ¾Æ´Ï°í Ä¡·áÀÇ ±ØÈ÷ ÀϺκР°úÁ¤ÀÔ´Ï´Ù. ¸ÞÁ¶´Â Å»¸ðÄ¡·á¿¡ ¾à°£ÀÇ ¿µÇâÀ» ÁÖÁö¸¸ ±Ùº»ÀûÀÌÁö´Â ¾Ê½À´Ï´Ù. »ý°¢Çغ¸¸é ¸ÞÁ¶¿¡ °ú´ÙÇÑ °ü½ÉÀº Àý´ë·Î Å»¸ð¸¦ ±Øº¹ÇÒ ¼ö ¾ø°í ÀÇ»çÀÚ½ÅÀ̳ª ȯÀÚ¿¡°Ôµµ Àڽۨ °á¿©¸¦ ÃÊ·¡ÇÒ »ÓÀÔ´Ï´Ù. 1-2ÁÖ°£°ÝÀ¸·Î ¹Þ´Â ±â±¸Ä¡·á(Àû¿Ü¼±, ½ºÆÀ, Çï·ý·¹ÀÌÁ®, LLLÄ¡·á, PRP, µÎÇÇÁö¹æÀ̽ĵî)°¡ ¾ó¸¶³ª Å»¸ð¿¡ µµ¿òÀÌ µÇ°Ú½À´Ï±î? Å©°Ô µµ¿òÀÌ µÇÁö ¾Ê½À´Ï´Ù. Å»¸ðȯÀÚ¿¡ ´ëÇÑ Á¾ÇÕÀûÀΠdzºÎÇÑ ÀÇÇÐÁö½ÄÀÌ È¯ÀÚ¸¶´Ù ´Ù¸¥ ¸öÀÇ ³»ºÎÀûÀÎ °ÍÀ» ½Äº°ÇÏ°í ±×°Í¿¡ µû¸¥ Ä¡·á°¡ ÇÊ¿äÇÕ´Ï´Ù. ÇÑ¿¹¸¦ µé¾î Ä¡·á°¡ ¾î·Á¿î ¿©¼ºÀÇ ³²¼ºÇü Å»¸ð(¿©ÀÚ ´ë¸Ó¸®)¿¡¼ ¸¸¼º½ºÆ®·¹½º´Â ¿ì¸®¸ö³×¼ Á¦ÀÏ Áß¿äÇÑ ½ºÆ®·¹½º ¹æ¾î±â°üÀÎ ¸ð·Á 50°³ÀÇ È£¸£¸óÀÌ ºÐºñµÇ´Â ºÎ½ÅÀ» ÈïºÐ½ÃÅ°°Å³ª °í°¥ ½Ãŵ´Ï´Ù. ¿©¼º¿¡¼ ºÎ½ÅÇǷδ ³²¼º°ú ´Þ¸® °¡¸¸È÷ À־ ºü¸£¸é 30´ë Á߹ݺÎÅÍ ½ÃÀ۵ǰí Æó°æ±â°¡ µÇ¸é ¿¡½ºÆ®·Î°Õ ¿ì¼¼(estrogen dominance)·Î ¿©¼º ´ëºÎºÐÀº Á¤µµ¿¡ Â÷ÀÌ°¡ ÀÖÁö¸¸ ºÎ½Å±â´É°ú °©»ó¼± ±â´ÉÀÌ ÀúÇϵ˴ϴÙ, ºÎ½ÅÇǷδ ºÎ½Å¿¡ Å×½ºÅ佺Å×·ÐÀ» Áõ°¡½ÃÅ°¸ç Àν¶¸° ÀúÇ×¼ºÀ» Åä·¡½ÃÄÑ¸ç °úÀν¶¸°ÁõÀº Å×½ºÅ佺Å×·ÐÀ» Áõ°¡½ÃÄÑ Å»¸ð¸¦ À¯¹ßÇÏ°Ô µË´Ï´Ù. ±×»Ó ¾Æ´Ï¶ó ¼ºÀå È£¸£¸ó, ÇÁ·Î°Ô½ºÅ×·Ð,¸á¶óÅä´Ñµî ¸ðµç °ÍÀÌ °¨¼ÒÇÏ°Ô µË´Ï´Ù. ¿ì¸®¸öÀÇ ´ëµéº¸ÀÎ ³úÇϼöü-ºÎ½ÅÃàÀÌ ¹«³ÊÁö¸é ºÎ½Å-°©»ó¼± Ãà(AT axis), ºÎ½Å-°©»ó¼±-³¼ÒÃà(OAT axis), ºÎ½Å-³ú ,ÃéÀå ,À§Àå°ü°è, Àν¶¸° ÀúÇ×¼ºµî,¸ðµç °ÍÀÌ µ¿½Ã¿¡ ¹«³ÊÁ® ÀÌ·±°ÍÀ» ÇØ°áÇÏÁö ¾Ê°í´Â ¿©¼ºÇü Å»¸ð°¡ ÀüÇô ÇØ°áµÉ ¼ö ¾ø½À´Ï´Ù. ÀÌ·± Å»¸ðȯÀÚ¿¡°Ô Å»¸ðÄ¡·á»Ó ¾Æ´Ï¶ó ºÎ½Å°í°¥·Î ¿À´Â ¸¸¼ºÇÇ·Î, ¿ì¿ï, ¼ö¸éÀå¾Ö, ±ÙÀ°Åë°ú °üÀýÅë,±â¾ï·Â¹× ÁýÁß·ÂÀå¾Ö, ¹«±â·Â, ±âºÐÀÇ ¾÷´Ù¿îµîÀÇ °íÂ÷¿øÀÇ Ä¡·á, ±×¸®°í ºÎ½ÅÇǷηΠ¿À´Â °¡Àå Áß¿äÇÑ ¿¡³ÊÁö È£¸£¸ó(ÄÚƼ¼Ö, °©»ó¼± È£¸£¸ó)ÀÇ ºÎÁ·À¸·Î ¿À´Â ±Þ°ÝÇÑ ¾ó±¼ ³ëÈ¿¡ ÇǺι̿ë Ä¡·á¸¦ °âÇÒ ¼ö ÀÖ¾î ¸ö³»¿ÜºÎÀÇ Ä¡·á¸¦ ÅëÇØ ÈǸ¢ÇÑ Àǻ簡 µÉ ¼ö ÀÖ½À´Ï´Ù. ±×¸®°í ¸ð¹ß Áٱ⼼Æ÷ÀÇ È°¼ºÈ¿¡ ´ëÇÑ Ä¡·á¿¡ ´õ¿í °ü½ÉÀ» ÇÊ¿ä·Î ÇÕ´Ï´Ù. ÇöÀç ¸ð¹ß Áٱ⠼¼Æ÷ Á÷Á¢Åõ¿©´Â ¾ÆÁ÷ ¿¬±¸ÁßÀÌ°í ´Ù¸¥ ºÎÀÛ¿ë(¸ð¹ßÀÇ ºñ±ÕÀÏÈ, ¸ð¹ßÀÇ ¸ðÀÓ, ¾Ï¹ß»ýµî)°ú °á°ú°¡ ¶Ñ·ÇÇÏÁö ¾Ê½À´Ï´Ù, ±×·¯³ª ±âÁ¸¿¡ ÀÖ´Â ¸ð¹ß Áٱ⼼Æ÷¸¦ ¿¡³ÊÁö È°¼ºÈ½ÃÅ°´Â Ä¡·á´Â ºÎÀÛ¿ë¾øÀÌ ÁÁÀº È¿°ú¸¦ º¼ ¼ö ÀÖ½À´Ï´Ù. ±Ô°Ýȵǰí Åø¾È¿¡ °°ÇôÀÖ´Â ÀÇ·áÀÇ Æ²¿¡¼ ¹þ¾î ³ª¾ß ÇÕ´Ï´Ù. °¨»çÇÕ´Ï´Ù * Çϵå¿þ¾î°¡ ¾Æ´Ñ ¼ÒÇÁÆ®¿þ¾î·Î Å»¸ð¿¡ ´ëÇÑ ÃæºÐÇÑ Áö½Ä°ú °æÇèÀ¸·Î ´Ù¸¥ ¹Ì¿ëÄ¡·á½Ã ¿À´Â ½ºÆ®·¹½ºµµ ¹ÞÁö¾Ê°í ³ªÀÌ°¡ µé¾îµµ ¾Æ¹«µµ ¹üÁ¢ÇÒ ¼ö ¾ø´Â °íÀ¯ÀÇ ³ëÇϿ츦 °¡Áö±æ ¹Ù¶ø´Ï´Ù. *Æ¿¸ð Ŭ¸®´ÐÀÌ ¾ø¾îµµ ¿øÇüÅ»¸ð, °¡º¿î ³²¼ºÇüÅ»¸ð, ÈÞÁö±â Å»¸ð, Ç×¾ÏÁ¦ Ä¡·áÈÄ Å»¸ð¸¦ ±âÁ¸Ä¡·á°¡ ¾Æ´Ñ »õ·Î¿î Ä¡·á·Î ½±°Ô Ä¡·áÇÒ ¼ö ÀÕ½À´Ï´Ù.
*°»ç À̱âÁö ÃÖ±Ù ÀÇÇÐ ³í¹® 1. ³²¼º°ú ¿©¼ºÀÇ ³²¼ºÇü Å»¸ðÁõ¿¡ ÀÖ¾î º¹ÇÕÄ¡·áÀÇ È¿°ú( 2010³â) (Effect of combination theraphy in male & female pattern alopecia) 2.ºÎ½ÅÇǷθ¦ µ¿¹ÝÇÑ ¿©¼ºÀÇ ³²¼ºÇü Å»¸ðÀÇ Ä¡·á(2010³â) (Treatment of Female Pattern Hair Loss in association with Adrenal Fatigue) 3.»çÃá±â ¼Ò³âÀÇ ³²¼ºÇü Å»¸ðÀÇ Ä¡·á(2011³â) (Treatment of Androgenetic Alopecia in Adolescents) 4.¿øÇüÅ»¸ðÀÇ º¹ÇÕÄ¡·áÀÇ È¿°ú(2011³â) (Effect of combination theraphy of Alopecia Areata in Korea) 5.¿©¼ºÀÇ ³²¼ºÇü Å»¸ðÄ¡·á ÀÖ¾î group A(minoxidil+mesotheraphy)¿Í group B(minoxidil+mesotheraphy+spironolactone)ÀÇ ºñ±³¿¬±¸(2012³â) (The comparative study of group A( topical minoxidil+mesotheraphy) and group B(topical minoxidil+mesotheraphy+spironolactone) in Female Pattern Hair Loss) 6. ´Ü°è 3 ºÎ½ÅÇÇ·Î(ºÎ½Å°í°¥)ÀÇ ºÎ½Åº¸ÃæÁ¦Ä¡·áÀÇ ºñ±³¿¬±¸(2012³â) (The comparative study of 4 month adrenal supplementation theraphy at stage 3 adrenal fatigue(adrenal exhaustion) 7.ºÎ½ÅÇÇ·Î¿Í ¿ì¿ï(ÀÚ»ìÇൿ)°úÀÇ »ó°ü°ü°è¿¡ ´ëÇÑ ¿¬±¸(2012³â) (Study in relationship between adrenal fatigue and depression(or sucidal behavior) 8.ºÎ½Å°í°¥ÀÇ Áø´Ü°ú ȸº¹ÁöÇ¥·Î¼ µ¿°øÈ®´ë°Ë»çÀÇ À¯¿ë¼º¿¡ ´ëÇÑ ¿¬±¸(2013³â) (Study in availability of pupil dilatation test as adrenal exhaustion & recovery indigator) 9.ºÎ½Å°í°¥ phase B(ºÎ½ÅÇÇ·Î 3´Ü°è phase B) ȯÀÚ ÄÉÀ̽º ¿¬±¸ (2013³â) (Adrenal Exhaustion phase B(Adrenal Fatigue Stage 3 phase B) Case Study 10. ºÎ½ÅÇǷθ¦ µ¿¹ÝÇÑ ÀüµÎÇü Å»¸ðÁõÀÇ ½ºÅ×·ÎÀ̵åÄ¡·á(intralesional or oral)¾øÀÌ ºÎ½ÅÀÚüġ·á¸¦ ÅëÇÑ Ä¡·áÈ£Àü ÄÉÀ̽º(2013³â) (Alopecia Totallis in association with Adrenal Fatigue Case Study 11ºÎ½Å°í°¥À» µ¿¹ÝÇÑ ¼¶À¯±ÙÀ°ÅëȯÀÚ¿¡¼ ±ÙÀ°ºÒ±ÕÇü°ú ôÃß»À ¿Ö°î»çÀÌÀÇ »óÈ£°ü°è¿¡ ´ëÇÑ ¿¬±¸ (Study of relationship between muscle imbalance and erecta spine deformity in fibromyalgia associated with adrenal exhaustion)(2013³â) 12.ºÎ½Å°í°¥À» µ¿¹ÝÇÑ ´Ù³¶¼º ³¼Ò ³¶Á¾ÀÇ ÄÉÀ̽º ¿¬±¸(2·Ê)(Casestudy of polycystic ovarian syndrome associated with adrenal exhaustion(2014³â) 13. ºÎ½ÅÇǷθ¦ µ¿¹ÝÇÑ ¾È¸é½Å°æ¸¶ºñÀÇ Ä¡·á(2014³â) (Treatment of facial nerve paralysis associated with adrenal fatigue 14.ÅΰüÀý Àå¾Ö¿Í ¸öÀÇ ÀÚ¼¼¿ÍÀÇ »óÈ£°ü°è¿¡ ´ëÇÑ ¿¬±¸(2014³â) (Study in relationship between Temporomandibular Joint Disorder and Body Posture) 15.½Å°æ°ú ±ÙÀ° ¼¼Æ÷¿¡³ÊÁö(ATP)°¡ Bell's Palsy¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ¿¬±¸(2014³â) (Study in effect of Nerve & Muscle cellular energy on Bell's Palsy) 16.¸¸¼ºÀûÀÎ ±ÙÀ° ´ÜÃà°ú ŸÀÌÆ®ÇÔÀÌ »À¿Í °üÀýº¯Çü¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ¿¬±¸(Study in effects of chronically muscle shortening & tightness on bone and joint deformity)
###°»ç À̱âÁö ÀÇÇÐÀú¼: 1. ÃֽŠŻ¸ðÁõÀÇ °ü¸®¿Í Ä¡·á 2. ÃֽŠŻ¸ðÁõÀÇ Áø´Ü°ú Ä¡·á 3. Alopecia(Å»¸ðÁõ) 4. Best Alopecia 5. All of Alopecia: ÃÑ 6±Ç 3500ÆäÀÌÁö 6. Easy Alopecia 7. ºÎ½ÅÇÇ·Î(Adrenal Fatigue) 8. ÇǺΠÀç»ý(Skin Regeneration) 9.¾Ç°üÀýÀå¾Ö(ÅΰüÀýÀå¾Ö):630ÆäÀÌÁö 10.¸ð¹ß¼Ò½Ç(Hair Loss):»óÇÏ 1600ÆäÀÌÁö 11, ±ÙÀ°Àç»ýÇÐ:900ÆäÀÌÁö 12.¾È¸é ½Å°æ¸¶ºñ:680ÆäÀÌÁö 13, ¼¶À¯ ±ÙÀ°Åë(Fibromyalgia)
|